doi:10.1007/s12250-018-0031-4

[1]
Xuechao Zhao, Lingyu Qian, Deyu Zhou, Di Qi, Chang Liu, Xiaohong Kong, 2016: Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region, Virologica Sinica, 31, 199-206. doi: 10.1007/s12250-016-3681-0
[2]
邓刚, 莎日娜, 母俊杰, 乔文涛, 耿运琪, 陈启民*, 2004: JDV Tat Transactivate LTR Involves Similar Cytokines as HIV-1 Tat, Virologica Sinica, 19, 576-581.
[3]
Shi-meng ZHANG, Rong FAN, Tian-yi YANG, Yi1 SUN, Jing-yun LI, Qin-zhi XU, Ping-kun ZHOU, 2009: An Improved Strategy for Efficient Expression and Purification of Soluble HIV-1 Tat Protein in E.coli, Virologica Sinica, 24, 518-528. doi: 10.1007/s12250-009-3068-6
[4]
Ling Ma, Shumin Chen, Zhen Wang, Saisai Guo, Jianyuan Zhao, Dongrong Yi, Quanjie Li, Zhenlong Liu, Fei Guo, Xiaoyu Li, Pingping Jia, Jiwei Ding, Chen Liang, Shan Cen, 2021: The CREB Regulated Transcription Coactivator 2 Suppresses HIV-1 Transcription by Preventing RNA Pol Ⅱ from Binding to HIV-1 LTR, Virologica Sinica, 36, 796-809. doi: 10.1007/s12250-021-00363-1
[5]
Xia FENG, Shuang-qing YU, Tsugumine Shu, Tetsuro Matano, Mamoru Hasegawa, Xiao-li WANG, Hong-tao MA, Hong-xia LI, Yi ZENG, 2008: Immunogenicity of DNA and Recombinant Sendai Virus Vaccines Expressing the HIV-1 gag Gene, Virologica Sinica, 23, 295-304. doi: 10.1007/s12250-008-2946-y
[6]
YoungHyun Shin, Chul Min Park, Hong Gi Kim, Dong-Eun Kim, Min Suk Choi, Jeong-ah Kim, Byeong-Sun Choi, Cheol-Hee Yoon, 2021: Identification of Aristolactam Derivatives That Act as Inhibitors of Human Immunodeficiency Virus Type 1 Infection and Replication by Targeting Tat-Mediated Viral Transcription, Virologica Sinica, 36, 254-263. doi: 10.1007/s12250-020-00274-7
[7]
Wenyuan Shen, Bin Liu, Zhou Liu, Jiabin Feng, Chang Liu, Xiaohong Kong, 2017: Host protein atlastin-1 promotes human immunodeficiency virus (HIV-1) replication, Virologica Sinica, 32, 338-341. doi: 10.1007/s12250-017-3998-3
[8]
Lei GUO, Ying ZHANG, Yan-chun CHE, Wen-juan WU, Wei-zhong LI, Li-chun WANG, Yun LIAO, Long-ding LIU, Qi-han LI, 2008: Interactions of the HSV-1 UL25 Capsid Protein with Cellular Microtubule-associated Protein, Virologica Sinica, 23, 211-217. doi: 10.1007/s12250-008-2936-9
[9]
Hong YU, Zong-tao LIU, Rui LV, Wen-qing ZHANG, 2010: Antiviral Activity of Recombinant Cyanovirin-N against HSV-1, Virologica Sinica, 25, 432-439. doi: 10.1007/s12250-010-3131-3
[10]
Yi Hu, Jingxin Zhang, 2013: Screening Strategies to Identify Host Factors Associated with the Early and Late Stages of HIV-1 Life Cycle, Virologica Sinica, 28, 242-245. doi: 10.1007/s12250-013-3359-9
[11]
柯昌文, 李天成, 武田直和, 2005: Positively Charged Amino Acid Residues of VP1 Capsid Protein of Human Polyomavirus BK Influence on the Formation of Virus-like Particles Generated by Recombinant Baculoviruses, Virologica Sinica, 20, 20-23.
[12]
Yan-chun CHE, Li JIANG, Qi-han LI, 2008: Molecular Modification of a HSV-1 Protein and Its Associated Gene Transcriptional Regulation, Virologica Sinica, 23, 394-398. doi: 10.1007/s12250-008-2994-z
[13]
Bin Liu, Ting-Ting Gao, Xiao-Yu Fu, Zhen-Hao Xu, Hao Ren, Ping Zhao, Zhong-Tian Qi, Zhao-Ling Qin, 2021: PTEN Lipid Phosphatase Activity Enhances Dengue Virus Production through Akt/FoxO1/Maf1 Signaling, Virologica Sinica, 36, 412-423. doi: 10.1007/s12250-020-00291-6
[14]
王福祥, 潘艳, 孙永涛, 2005: Chemokine Genes Modulate Immune Responses Induced by HIV-1 Envelope Protein Gene Vaccine, Virologica Sinica, 20, 578-581.
[15]
童贻刚, 杜勇, 徐静, 李敬云, 鲁晏希, 鲍作义, 王海涛, 2000: High Level Soluble Expressiion，One-Step Purification and Characterization of HIV-1 p24 Protein, Virologica Sinica, 15, 116-121.
[16]
Wei-ming YAN, Jia-quan HUANG, Xiao-ping LUO, Qin NING, 2007: Expression of Prothrombinase/fibroleukin Gene fg12 in Lung Impairment in a Murine Severe Acute Respiratory Syndrome Model, Virologica Sinica, 22, 181-192.
[17]
Taiwu Wang, Hui Lin, Lu Zhang, Guorong Huang, Long Wu, Lei Yu, Hongyan Xiong, 2015: Expression and purification of recombinant lyase gp17 from the LSB-1 phage in Escherichia coli, Virologica Sinica, 30, 69-72. doi: 10.1007/s12250-014-3527-6
[18]
Jianjian Li, Lin Li, Shaomin Yang, Jingyun Li, Mi Zhang, Cuixian Yang, Jiafa Liu, Huiqin Li, 2016: Identification and characterization of two human immunodeficiency virus type 1 unique recombinant forms from Yunnan, China, Virologica Sinica, 31, 184-187. doi: 10.1007/s12250-015-3671-7
[19]
毛春生, 金宁一, 佟明华, 郭军庆, 王秀清, 郭志儒, 殷震, 1998: Effects of long terminal repeat (LTR) of human immunodeficiency virus type 1 on the expression of gag gene in recombinant vaccinia viruses, Virologica Sinica, 13, 207-.
[20]
栾怡, 于修平, 宋长芹, 卞继峰, 赵蔚明, 贾继辉, 周亚滨, 齐眉, 2002: Comparison of Detection Antibodies to Human papillomaviruses 16 L1 in the Cervical Cancer People with Different Recombinant Antigen, Virologica Sinica, 17, 308-311.